How Targeted Therapy Achieves Responses Across Multiple Cancer Types?
Erdafitinib is the first approved FGFR-targeted treatment for advanced urothelial cancer, reveal scientists.
Stay updated with breaking news from Penn Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Erdafitinib is the first approved FGFR-targeted treatment for advanced urothelial cancer, reveal scientists.
Leading and reliable source of health news updates round the clock on Friday, June 2, 2023 with RSS feeds
Penn engineers have created a novel photonic device that provides programmable on-chip information processing without lithography, offering the speed, accuracy, and flexibility for AI applications.
Penn Engineering’s Michael Posa discusses robotics in the age of artificial intelligence, the ambulatory genius of toddlers, navigating the unfamiliar and the elegance of not learning everything.
The Environmental Innovations Initiative announces a third round of funded research communities to catalyze interdisciplinary research at Penn, investigating issues from regenerative agriculture to project-based learning for global climate justice.